Market closed

Becton Dickinson/$BDX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Becton Dickinson

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Ticker

$BDX

Sector

NON_CLASSIFIED

Trading on

NYSE

Industry

Medical Equipment & Supplies

Headquarters

Franklin lakes, United States

Employees

73,000
Website

Becton Dickinson Metrics

BasicAdvanced
$67B
51.07
$4.54
0.45
$3.72
1.64%
$67B
0.45
$287.32
$224.00
30M
$3.72
1.411
0.971
62.366
70.227
79.03%
45.037
6.91%
2.54%
5.31%
2.94%
51.072
3.4
2.627
34.845
1.40%
1.60%
1.64%
4.82%
-13.64%
6.42%
80.44%
4.83%

What the Analysts think about Becton Dickinson

Analyst Ratings

Majority rating from 17 analysts.
Buy

Becton Dickinson Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.64% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$5B
7.20%
Net income
$537M
90.43%
Profit margin
10.64%
77.63%

Becton Dickinson Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 6.76%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$2.96
$3.42
$2.68
$3.17
-
Expected
$2.91
$3.43
$2.40
$2.97
$3.31
Surprise
1.59%
0.16%
11.66%
6.76%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BDX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Becton Dickinson stock?

Becton Dickinson (BDX) has a market cap of $67B as of April 24, 2025.

What is the P/E ratio for Becton Dickinson stock?

The price to earnings (P/E) ratio for Becton Dickinson (BDX) stock is 51.07 as of April 24, 2025.

Does Becton Dickinson stock pay dividends?

Yes, the Becton Dickinson (BDX) stock pays dividends to shareholders. As of April 24, 2025, the dividend rate is $3.72 and the yield is 1.64%. Becton Dickinson has a payout ratio of 79.03% on a trailing twelve-month basis.

When is the next Becton Dickinson dividend payment date?

The next Becton Dickinson (BDX) dividend payment date is unconfirmed.

What is the beta indicator for Becton Dickinson?

Becton Dickinson (BDX) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.